Fatigue as hallmark of Fabry disease: role of bioenergetic alterations
Fabry disease (FD) is a lysosomal storage disorder due to the impaired activity of the α-galactosidase A (GLA) enzyme which induces Gb3 deposition and multiorgan dysfunction. Exercise intolerance and fatigue are frequent and early findings in FD patients, representing a self-standing clinical phenot...
Main Authors: | Jessica Gambardella, Eleonora Riccio, Antonio Bianco, Antonella Fiordelisi, Federica Andrea Cerasuolo, Antonietta Buonaiuto, Teodolinda Di Risi, Alessandro Viti, Roberta Avvisato, Antonio Pisani, Daniela Sorriento, Guido Iaccarino |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2024.1341590/full |
Similar Items
-
Cardiopulmonary determinants of reduced exercise tolerance in Fabry disease
by: Oriana De Marco, et al.
Published: (2024-05-01) -
Cardiac involvement in Anderson–Fabry disease. The role of advanced echocardiography
by: Letizia Spinelli, et al.
Published: (2024-09-01) -
Experimental evidence and clinical implications of Warburg effect in the skeletal muscle of Fabry disease
by: Jessica Gambardella, et al.
Published: (2023-03-01) -
GRKs and β-Arrestins: “Gatekeepers” of Mitochondrial Function in the Failing Heart
by: Daniela Sorriento, et al.
Published: (2019-02-01) -
New insights in efficacy of different ERT dosages in Fabry disease: Switch and switch-back studies data following agalsidase beta shortage. Update of systematic review
by: Eleonora Riccio, et al.
Published: (2023-01-01)